Page 37 - TD-3-2
P. 37

Tumor Discovery                                          Immunophenotypic patterns of childhood acute leukemia



            a tertiary care institute in Delhi, India. Informed consent   2016;127(20):2391-2405.
            for publication was not applicable as the study was      doi: 10.1182/blood-2016-03-643544
            retrospective, and there was no direct contact with patients.
            Data were retrieved from the departmental archive.  10.  Supriyadi  E,  Widjajanto  PH,  Veerman  AJ,  et al.
                                                                  Immunophenotypic patterns of childhood acute leukemias
            Availability of data                                  in Indonesia. Asian Pac J Cancer Prev. 2011;2(12):3381-3387.
                                                               11.  Pui CH, Behm FG, Crist WM. Clinical and biologic
            Data used in this work are available from the corresponding   relevance  of immunologic  marker  studies  in childhood
            author on reasonable request.                         acute lymphoblastic leukemia. Blood. 1993;82(2):343-362.

            Further disclosure                                 12.  Sharma M, Sachdeva MU, Varma N, et al. Haematological
                                                                  profile of patients with mixed-phenotype acute leukaemia
            The findings have been presented in a conference DAPCON   from a tertiary care centre of North India. Indian J Med Res.
            July 31, 2022, at AIIMS, New Delhi, India as a poster.  2017;145(2):215-221.
            References                                            doi: 10.4103/ijmr.IJMR_324_14

            1.   Schrappe M, Reiter A, Zimmermann M, et al. Long-term   13.  Rajalekshmy KR, Abitha AR, Anuratha N, et al. Time trend
               results of four consecutive trials in childhood ALL performed   in frequency of occurrence of major immunophenotypes in
               by the ALL-BFM study group from 1981 to 1995. Berlin-  paediatric acute lymphoblastic leukemia cases as experienced
               Frankfurt-Münster. Leukaemia. 2000;14(12):2205-2222.  by Cancer Institute, Chennai, south India during the period
                                                                  1989-2009. Indian J Cancer. 2011;48(3):310-315.
               doi: 10.1038/sj.leu.2401973
                                                                  doi: 10.4103/0019-509X.84932
            2.  Muller-Berndorff  H,  Haas  PS,  Kunzmann  R,
               Schulte-Monting  J, Lubbert M.  Comparison  of  five   14.  Sharma M, Sachdeva MU, Varma N, Varma S, Marwaha RK.
               prognostic  scoring  systems,  the  French  American-British   Characterization of immunophenotypic aberrancies in adult
               (FAB) and World Health Organization (WHO) classifications   and childhood acute lymphoblastic leukaemia: A study from
               in  patients  with  myelodysplastic  syndromes:  Results  of  a   Northern India. J Can Res. 2016;12(2):620-626.
               single-centre analysis. Ann Hematol. 2006;85(8):502-513.     doi: 10.4103/0973-1482.147716
               doi: 10.1007/s00277-005-0030-z                  15.  Roy  S,  Nath S,  Goswami  RR, Sheikh,  SA. Clinico-
            3.   Swerdlow SH, Campo E, Harris NL,  et  al, editors.  WHO   hamatological study of leukaemias in a hospital-based setup.
               Classification of Tumours of Haematopoietic and Lymphoid   Int J Res Med Sci. 2022;10(1):185-190.
               Tissues. Lyon, France: IARC; 2016.                 doi: 10.18203/2320-6012.ijrms20215052
            4.   Borowitz MJ. Acute leukaemia of ambiguous lineage.   16.  Agarwal V, Dabadghao S, Misra MN, Nityanand S.
               In: Swerdlow SH, Campo E, Harris NL, editors.  WHO   Immunophenotypic subsets in acute lymphoblastic
               Classification of Tumours of Haematopoietic and Lymphoid   leukemia from a single centre in North India: Correlation
               Tissues. 4  ed. Lyon: IARC Press; 2008. p. 150-155.  with the outcome to induction chemotherapy.  Indian J
                      th
                                                                  Cancer. 2001;38(2-4):85-91.
            5.   Killick S, Matutes E, Powles RL, et al. Outcome of biphenotypic
               acute leukemia. Haematologica. 1999;84(8):699-706.  17.  Rajalekshmy KR, Abitha AR, Pramila R, Gnanasagar T,
            6.   Bene MC, Castoldi G, Knapp W,  et al. Proposals for the   Maitreyan V, Shanta V. Immunophenotyping of acute
               immunological classification of acute leukaemias. European   lymphoblastic  leukaemia in  Madras,  India.  Leuk Res.
               Group for the immunological characterization of leukemias   1994;18(3):183-190.
               (EGIL). Leukaemia. 1995;9(10):1783-1786.           doi: 10.1016/0145-2126(94)90113-9

            7.   Pui CH,  Dahl GV, Melvin S,  et al. Acute  leukaemia with   18.  Gupta N, Pawar R, Banerjee S,  et al. Spectrum and
               mixed lymphoid and myeloid phenotype.  Br  J  Haematol.   immunophenotypic profile of acute leukaemia:  A  tertiary
               1984;56(1):121-130.                                center flow cytometry experience. Mediterr J Hematol Infect
                                                                  Dis. 2019;11(1):e2019017.
               doi: 10.1111/j.1365-2141.1984.tb01277.x
                                                                  doi: 10.4084/MJHID.2019.017
            8.   Bennett  JM,  Catovsky  D,  Daniel  MT,  et al.  Proposals
               for the classification of the acute leukaemias. French-  19.  Schrappe M, Moricke A, Reiter A,  et al. Key treatment
               American-British (FAB) co-operative group. Br J Haematol.   questions  in  childhood  acute  lymphoblastic  leukemia:
               1976;33(4):451-458.                                Results in 5 consecutive trials performed by the
                                                                  ALL-BFM study group from 1981 to 2000.  Klin Padiatr.
            9.   Arber DA, Orazi A, Hasserjian R,  et al. The 2016
               revision to the World Health Organization classification   2013;225(Suppl 1):S62-S72.
               of myeloid neoplasms and acute leukemia. Blood.      doi: 10.1055/s-0033-1337966


            Volume 3 Issue 2 (2024)                         8                                 doi: 10.36922/td.2545
   32   33   34   35   36   37   38   39   40   41   42